feeds

31.01.2023
2023

This month, the EMCDDA has launched two new projects which will intensify its cooperation with the Western Balkans and the European Neighbourhood Policy area (ENP). The EU-funded projects, running until the end of 2026 and 2027 respectively, will support national and regional readiness to identify and respond to drug-related health and security threats. The projects take place within the agency’s mandate for cooperation with third (non-EU) countries (1).

30.01.2023
2023

This month sees the start of a new phase of collaboration between the EMCDDA and Ukraine following the signing of a Working Arrangement between the agency and the Ukrainian Ministry of Health. The signatories of the agreement were EMCDDA Director Alexis Goosdeel and Ukrainian Minister of Health Viktor Liashko. Exchanging expertise, experience and methodology in drug monitoring will be at the heart of the collaboration.

18.01.2023
2023

Professionals, academics or experts from Latin American and Caribbean countries (LAC) (1) will have an opportunity to participate in the European Drugs Winter School (EDWS) this year, thanks to two bursaries covering the registration fee being offered through the EMCDDA’s partnership with the COPOLAD project.

13.01.2023
2023

This month, Sweden took over the rotating presidency of the Council of the EU with a pledge to focus on security, competitiveness, green and energy transitions, democratic values and the rule of law. Over the next six months, the country will lead work at all levels of the Council, building cooperation, agreement and solidarity between EU Member States.

2023

This paper describes the development and results of a web survey, named the Party Panel, that addresses emerging risks in nightlife settings. The survey does so by gathering the information that prevention organisations require to develop theory- and evidence-based behaviour change interventions. The survey supports the development of such interventions by mapping the determinants and sub-determinants of substance use-related behaviours among Dutch nightlife participants.

2022

This timeline allows you to explore a timeline highlighting some of the EU4Monitoring Drugs (EU4MD) project's achievements. As part of its ongoing commitment to strengthening cooperation and sharing expertise, EMCDDA developed the EU4Monitoring Drugs (EU4MD) project, funded by the European Union. The project has been running from 2019 until 2022 and involves countries in the European Neighbourhood Policy (ENP) area. It supports national and regional readiness to identify and respond to drug-related security and health threats.

19.12.2022
2022

On 16 December, the EMCDDA held the first ‘Technical expert meeting on hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSCs)’ as part of its ongoing work to support EU and national preparedness and response to emerging NPS risks. Hexahydrocannabinol is the first semi-synthetic cannabinoid reported in the EU and has been monitored as a NPS by the EU Early Warning System since 21 October 2022.

19.12.2022
2022

This month, the Czech six-month Presidency of the Council of the EU draws to a close. With the motto ‘Rebuild, Rethink, Repower’, the Presidency focused on five key priorities: managing the refugee crisis and post-war reconstruction of Ukraine; energy security; strengthening European defence capabilities and cybersecurity; strategic resilience of the European economy; and the resilience of democratic institutions.

16.12.2022
2022

As we reach the end of 2022, we look back on a year which has seen Europe face the trials of war, growing instability in food and energy supplies and ongoing social and economic challenges as we emerge from the COVID-19 pandemic. At this time, our thoughts are with those most affected and we hope for more peaceful times ahead.

When I reflect on the past 12 months, I feel proud of the way in which the EMCDDA team has once again adapted to uncertainty and change in the European landscape and has worked to provide useful and relevant analyses to inform drug policy and practice.

16.12.2022
2022

Four long-standing members of the EMCDDA Management Board received awards this week in recognition of their extraordinary dedication and service to the agency. The recipients were: 

Mr Franz Pietsch — Chairman of the Management Board since 1 January 2022. Mr Pietsch has been Austrian member of the Board since 2002. He is currently Deputy Director-General and Head of the Human Medicines Law Division at the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection.

13.12.2022
2022

Belgian Minister of the Interior, Institutional Reform and Democratic Renewal, Ms Annelies Verlinden, visited the EMCDDA this week during an official visit to Portugal. The Minister met EMCDDA Director Alexis Goosdeel who presented the work of the agency and its upcoming change of mandate. The focus of the visit was on public safety and security.

2022

This interactive timeline highlights some of the key achievements and milestones over the last 25 years of monitoring new psychoactive substances in Europe.

2022

This paper assesses data quality in the first two rounds of the European Web Survey on Drugs (EWSD). Data quality has various dimensions, such as accuracy, consistency, validity and completeness, but can be defined as fitness of the data for the intended use. For the quantitative assessment, the paper considers issues such as respondent fatigue and impact of the item format on responses.

09.12.2022
2022

This week, the EMCDDA participated in a meeting ‘Early warning systems in response to opioids and new psychoactive substances’, organised by the Inter-American Drug Abuse Control Commission (CICAD) of the Organisation of American States (OIS) and the Canadian authorities (1). The agency participated remotely in the event, which was held in Port of Spain, Trinidad and Tobago (7–8 December).

2022

This paper presents an overview of the European Web Survey on Drugs (EWSD), a project which began in 2016 with the aim of developing a system for collecting novel data from people who use drugs of value to the EMCDDA and its national partners. 

This publication is published as part of a collection of papers on web surveys: Monitoring drug use in the digital age: studies in web surveys (Insights 26).

08.12.2022
2022

Responding to drug problems in families and among those experiencing homelessness is the focus of two new EMCDDA miniguides released today. The resources are the first of five volumes dedicated to people with vulnerability and form part of the agency’s Health and social responses to drug problems: a European guide.

07.12.2022
2022

The Georgian version of the European Prevention Curriculum (EUPC) handbook, adapted to the national context, will be launched at two events in Tbilisi on 8 and 9 December.

2022

This miniguide is part of the Health and social responses to drug problems: a European guide.

For an overview of the miniguides available, please visit the European Responses Guide page.

You can subscribe to be informed by e-mail once this publication has been launched

2022

This miniguide is part of the Health and social responses to drug problems: a European guide.

For an overview of the miniguides available, please visit the European Responses Guide page.

You can subscribe to be informed by e-mail once this publication has been launched

01.12.2022
2022

Today, Members of the European Parliament (MEPs) from the Civil Liberties Committee (LIBE) adopted a report creating the European Union Drugs Agency and endowing it with new competences.

29.11.2022
2022

The nine EU Agencies active in the field of freedom, security and justice convened today in Budapest for a high-level meeting, chaired by CEPOL, to take stock of the main achievements in 2022, which includes the ongoing engagement with Ukraine and Moldova. 

28.11.2022
2022

Today, the EMCDDA signed its first working arrangement with the European Agency for Law Enforcement Training (CEPOL) in Budapest aimed at boosting learning and knowledge exchange in the area of security. The signatories were EMCDDA Director Alexis Goosdeel and CEPOL Executive Director Montserrat Marín López.

28.11.2022
2022

Heads of the national focal points (NFPs) of the Reitox network are meeting in Lisbon today to discuss network business and the planning of activities for 2023. On the agenda of the three-day meeting are discussions on the revision of the new EMCDDA mandate, international cooperation projects and recent and future policy and institutional developments.

21.11.2022
2022

EMCDDA staff members will be among the 1 000 speakers gathering this week in Lisbon at the European Conference on Addictive Behaviours and Dependencies (Lisbon Addictions 2022).

Under the overarching theme of ‘Global Addictions’, the event will showcase the latest scientific knowledge in this domain and explore challenges relating to illicit drugs, alcohol, tobacco, screen addiction, gambling and other addictive behaviours. It is the largest European conference in the area of addictions.

2022

This interactive map presents some of the main highlights from countries within the Reitox network of national focal point's for the year 2022.

2022

This paper looks at the implementation and recruitment strategies of the 2016 European Web Survey on Drugs (EWSD) in France. It also explores the possibility of generalising the EWSD results by using a matching procedure that links EWSD respondents with respondents of the 2017 general population survey (GPS) in France.

This publication is published as part of a collection of papers on web surveys: Monitoring drug use in the digital age: studies in web surveys (Insights 26).

21.11.2022
2022

This week, the EMCDDA is hosting the closing conference of its international cooperation projects with the Western Balkans and European Neighbourhood Policy (ENP) region (1). The two-day event, kicking off today, is being held in the margins of Lisbon Addictions 2022, Europe’s largest conference in the area of addictions.

18.11.2022
2022

Drug-related health and security threats in the Western Balkans are highlighted today in a new report published by the EU drugs agency (EMCDDA). Released in the framework of the agency’s latest Instrument for Pre-accession Assistance project (IPA7), funded by the EU, the report provides the latest picture of the drug situation in the region (1).

18.11.2022
2022

The emergence of new drug trafficking routes, the expansion of online markets, and the availability of a broader spectrum of substances, are among the findings highlighted in two new reports published today by the EU drugs agency (EMCDDA) (1). Released in the framework of the EU-funded EU4Monitoring Drugs project (EU4MD), the reports provide a picture of the drug market in the eastern and southern European Neighbourhood Policy regions (ENP-East and ENP-South) (2).

Loading